| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT05099172 First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung… |
overall status: "Active Not Recruiting" → "Recruiting" |
| 2026-06-12 | NCT05099172 First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung… |
Trial sites expanded: 81 -> 94 locations |
| 2026-06-12 | NCT05099172 First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung… |
date change Completion pushed: 2026-12-31 -> 2029-06-29 |
| 2026-06-12 | NCT07557147 Single-arm, Multi-center Study Evaluating the Acceptance and Feasibility of a Digital… |
date change Primary completion pushed: 2027-11-22 -> 2028-02-28 |
| 2026-06-12 | NCT07557147 Single-arm, Multi-center Study Evaluating the Acceptance and Feasibility of a Digital… |
date change Completion pushed: 2027-12-22 -> 2028-03-28 |
| 2026-06-11 | NCT06914128 A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors |
Primary endpoint(s) modified |
| 2026-06-09 | NCT07582328 A Study to Learn More About How Well Oxymetazoline HCl 0.05% Nasal Gel Works and How Safe… |
Trial completed |
| 2026-06-09 | NCT07582328 A Study to Learn More About How Well Oxymetazoline HCl 0.05% Nasal Gel Works and How Safe… |
date change Primary completion moved earlier: 2026-08-07 -> 2026-05-28 |
| 2026-06-09 | NCT07582328 A Study to Learn More About How Well Oxymetazoline HCl 0.05% Nasal Gel Works and How Safe… |
date change Completion moved earlier: 2026-08-07 -> 2026-05-28 |
| 2026-06-09 | NCT07298044 A Study to Learn More About the Change in the Blood Levels of Transthyretin When… |
date change Primary completion moved earlier: 2027-12-25 -> 2027-07-15 |
| 2026-06-09 | NCT07298044 A Study to Learn More About the Change in the Blood Levels of Transthyretin When… |
date change Completion moved earlier: 2027-12-25 -> 2027-07-15 |
| 2026-06-06 | NCT07192952 A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time… |
Recruitment opened |
| 2026-06-06 | NCT06914128 A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors |
Primary endpoint(s) modified |
| 2026-06-06 | NCT06914128 A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors |
Enrollment increased: 370 -> 450 participants |
| 2026-06-06 | NCT06914128 A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors |
Trial arms changed: 8 -> 9 |
| 2026-06-06 | NCT07176728 A Study to Assess the Safety and Effects of Different Doses of an Investigational Drug… |
Trial completed |
| 2026-06-03 | NCT05348733 A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine… |
date change Primary completion pushed: 2026-10-26 -> 2027-09-01 |
| 2026-06-03 | NCT05348733 A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine… |
date change Completion pushed: 2026-12-15 -> 2027-12-15 |
| 2026-05-30 | NCT07446010 Post Approval Observational Study to Learn More About How Safe Octocog Alfa is and How… |
date change Primary completion pushed: 2026-12-31 -> 2027-09-30 |
| 2026-05-30 | NCT07446010 Post Approval Observational Study to Learn More About How Safe Octocog Alfa is and How… |
date change Completion pushed: 2026-12-31 -> 2027-09-30 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-04 | NCT07625215 A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05348876 | A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real… | Non-metastatic Castration-resistant Prostate Cancer | Recruiting |
| NCT07298044 | A Study to Learn More About the Change in the Blood Levels of Transthyretin When… | Transthyretin Amyloid Cardiomyopathy | Recruiting |
| NCT04597125 | RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs… | Metastatic Castrate Resistant Prostate Cancer (mCRPC) | Active, Not Recruiting |
| Phase 3 | |||
| NCT05196035 | A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it… | Chronic Kidney Disease | Recruiting |
| NCT06452277 | A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With… | Advanced Non-small Cell Lung Cancer | Recruiting |
| NCT07188805 | A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves… | Left Ventricular Systolic Dysfunction | Recruiting |
| NCT06904274 | Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months | Endometrial Hyperplasia | Recruiting |
| NCT05457283 | A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use… | Chronic Kidney Disease | Recruiting |
| NCT07192952 | A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time… | Left Ventricular Systolic Dysfunction | Recruiting |
| NCT04464226 | Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in… | Cancer | Active, Not Recruiting |
| NCT05587296 | A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to… | Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer | Active, Not Recruiting |
| NCT02562235 | Riociguat in Children With Pulmonary Arterial Hypertension (PAH) | Hypertension, Pulmonary | Active, Not Recruiting |
| NCT05794906 | A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo… | Biochemically Recurrent Prostate Cancer | Active, Not Recruiting |
| NCT07023341 | A Study to Learn More About How Well Aficamten Works in Japanese Participants With… | Obstructive Hypertrophic Cardiomyopathy | Active, Not Recruiting |
| Phase 2 | |||
| NCT07211685 | BAY3401016; Biomarker Study Alport | Alport Syndrome | Recruiting |
| NCT07450599 | A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy… | High-Risk Localized Prostate Cancer | Recruiting |
| NCT06760819 | A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets… | Advanced Solid Tumors | Recruiting |
| NCT05059236 | A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation… | Metastatic Hormone-sensitive Prostate Cancer | Active, Not Recruiting |
| NCT06246643 | A Study of Continued Treatment With Regorafenib in Participants With Solid Tumors Who… | Solid Malignant Tumors | Active, Not Recruiting |
| NCT07625215 | A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial… | Atrial Fibrillation | Not Yet Recruiting |
| NCT07566429 | A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease… | Parkinson Disease | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT06914128 | A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors | MTAP-deleted Solid Tumors | Recruiting |
| NCT05099172 | First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung… | Advanced Non-small Cell Lung Cancer | Recruiting |
| NCT03588299 | Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to… | Hemophilia A | Active, Not Recruiting |
| Phase 1 | |||
| NCT06764316 | A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in… | Hepatocellular Carcinoma | Recruiting |